Succinylcholine―tissue distribution and elimination from plasma in the dogNORDGREN, I; BALDWIN, K; FORNEY, R. JR et al.Biochemical pharmacology. 1984, Vol 33, Num 15, pp 2519-2521, issn 0006-2952Article

Reassessment of the concept of a therapeutic range of anticonvulsant plasma levelsVAJDA, F. J. E; AICARDI, J.Developmental medicine and child neurology (Print). 1983, Vol 25, Num 5, pp 660-671, issn 0012-1622Article

Dose-dependent metabolism, therapeutic effect, and toxicity of anticancer drugs in manPOWIS, G; GILLETT, J. R.Drug metabolism reviews (Softcover ed.). 1983, Vol 14, Num 6, pp 1145-1163, issn 0360-2532Article

Pharmacokinetics of heparin V: in vivo and in vitro factors affecting the relationship between concentration and anticoagulant effect of heparin in rat plasmaWHITFIELD, L. R; LEVY, G.Journal of pharmaceutical sciences. 1983, Vol 72, Num 10, pp 1141-1146, issn 0022-3549Article

Metabolism of aminoglutethimide in humans: quantification and clinical relevance of induced matabolismGOSS, P. E; JARMAN, M; GRIGGS, L. J et al.British journal of cancer. 1985, Vol 51, Num 2, pp 259-262, issn 0007-0920Article

Arzneimittel und Organismus. IV: Pro-drugs, ein Weg zur Arzneimitteloptimierung = Médicaments et organisme. IV: Promédicaments, une voie pour l'optimisation des médicaments = Drugs and organism. IV: Pro-drugs, a way to drug optimizationPFEIFER, S.Pharmazie. 1983, Vol 38, Num 10, pp 663-666, issn 0031-7144Article

Clinical pharmacology of propafenoneCONNOLLY, S. J; KATES, R. E; LEBSACK, C. S et al.Circulation (New York, N.Y.). 1983, Vol 68, Num 3, pp 589-596, issn 0009-7322Article

Induction of DNA repair synthesis in human urothelial cells by the N-hydroxy metabolites of carcinogenic arylamines = Induction de la synthèse de réparation du DNA dans les cellules urothéliales humaines par les métabolites N-hydroxy des arylamines carcinogènesCHING YUNG WANG; CHRISTENSEN, B; ZUKOWSKI, K et al.Journal of the National Cancer Institute. 1984, Vol 72, Num 4, pp 847-852, issn 0027-8874Article

Clinical relevance of thiothixene plasma levelsMAVROIDIS, M. L; KANTER, D. R; HIRSCHOWITZ, J et al.Journal of clinical psychopharmacology. 1984, Vol 4, Num 3, pp 155-157, issn 0271-0749Article

Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokineticsPIZZOLATO, G; SONCRANT, T. T; RAPOPORT, S. I et al.Journal of neurochemistry. 1984, Vol 43, Num 3, pp 724-732, issn 0022-3042Article

Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical useSIMPSON, G. M; FREDERICKSON, E; PALMER, R et al.Biological psychiatry (1969). 1985, Vol 20, Num 6, pp 684-687, issn 0006-3223Article

Doses of aminophylline given intravenously in casualty department and resulting serum theophylline concentrationsMUNRO, C. S; PROWSE, K.British medical journal (1857). 1984, Vol 289, Num 6441, pp 354-355, issn 0007-1447Article

The metabolism of triazene antitumor drugsGESCHER, A; THREADGILL, M. D.Pharmacology & therapeutics (Oxford). 1987, Vol 32, Num 2, pp 191-205, issn 0163-7258Article

An alternative model for the selection of therapeutic chelating agentsJONES, M. M.Inorganica chimica acta. 1985, Vol 107, Num 4, pp 235-241, issn 0020-1693Article

Binding to and antibacterial effect of aztreonam, temocillin, gentamicin and tobramycin on human faecesHAZENBERG, M. P; PENNOCK-SCHRÖDER, A. M; VAN DE MERWE, J. P et al.Journal of hygiene. 1985, Vol 95, Num 2, pp 255-263, issn 0022-1724Article

In consideration of active metabolitesPOYNOR, W. J.Journal of clinical pharmacology. 1987, Vol 27, Num 3, pp 167-168, issn 0091-2700Article

A common single binding site for many psychotropic drugs on human α₁-acid glycoprotein. Therapeutically relevant observation?MÜLLER, W. E.Pharmacopsychiatry. 1985, Vol 18, Num 4, pp 257-258, issn 0176-3679Article

Polyglutamation of methotrexate: is methotrexate a prodrug?CHABNER, B. A; ALLEGRA, C. J; CURT, G. A et al.The Journal of clinical investigation. 1985, Vol 76, Num 3, pp 907-912, issn 0021-9738Article

Toxicologie et pharmacologie moléculaires: métabolisme des médicaments. Prévision d'éventuels effets secondaires toxiques = Molecular toxicology and pharmacology: drug metabolism. Prospective toxical secondary effectsMANSUY, D.1985, 21 p.Report

Effects of the α-carboline, FG 7142, in the social interaction test of anxiety and the holeboard: correlations between behaviour and plasma concentrationsFILE, S. A; PELLOW, S; BRAESTRUP, C et al.Pharmacology, biochemistry and behavior. 1985, Vol 22, Num 6, pp 941-944, issn 0091-3057Article

Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribingWHITING, B; KELMAN, A. W; BRYSON, S. M et al.British medical journal (1857). 1984, Vol 288, Num 6416, pp 541-545, issn 0007-1447Article

On the mechanism for the red-cell accumulation of mefloquine, an antimalarial drugSAN GEORGE, R. C; NAGEL, R. L; FABRY, M. E et al.Biochimica et biophysica acta. 1984, Vol 803, Num 3, pp 174-181, issn 0006-3002Article

D-penicillamine in patients with rheumatoid arthritis: serum levels, pharmacokinetic aspects, and correlation with clinical course and side effectsMUIJSERS, A. O; VAN DE STADT, R. J; HENRICHS, A. M. A et al.Arthritis and rheumatism. 1984, Vol 27, Num 12, pp 1362-1369, issn 0004-3591Article

Delivery of active hexosaminidase across the blood-chain barrier in ratsNEUWELT, E. A; BARRANGER, J. A; PAGEL, M. A et al.Neurology. 1984, Vol 34, Num 8, pp 1012-1019, issn 0028-3878Article

The pharmacology of prodrugs of 5-fluorouracil and 1-β-D-arabinofuranosylcytosineHADFIELD, A. F; SARTORELLI, A. C.Advances in pharmacology and chemotherapy. 1984, Vol 20, pp 21-67, issn 0065-3144Article